A257 Pill - white round
Pill with imprint A257 is White, Round and has been identified as Clonidine Hydrochloride Extended-Release 0.1 mg. It is supplied by Par Pharmaceutical.
Clonidine is used in the treatment of ADHD; High Blood Pressure; Pain and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A257



Clonidine Hydrochloride Extended-Release
- Imprint
- A257
- Strength
- 0.1 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical
- Inactive Ingredients
-
silicon dioxide,
hydroxypropyl cellulose (type e),
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
10370-0257 (Discontinued) | Anchen Pharmaceuticals, Inc. |
68084-0866 (Discontinued) | Amerisource Health Services |
Related images for "A257"
More about clonidine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (770)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antiadrenergic agents, centrally acting
- Breastfeeding
Patient resources
- Clonidine drug information
- Clonidine injection
- Clonidine transdermal
- Clonidine (Epidural) (Advanced Reading)
Other brands
Catapres, Kapvay, Catapres-TTS, Onyda XR, ... +2 more
Professional resources
- CloNIDine, cloNIDine Hydrochloride monograph
- Clonidine (FDA)
- Clonidine Extended Release Tablets (FDA)
- Clonidine Injection (FDA)
- Clonidine Patch (FDA)
- Clonidine Tablets (FDA)
Other brands
Catapres, Kapvay, Catapres-TTS, Onyda XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.